Showing results (31-40 of 323) with videos related to
Sort By:
Pageof 33
Current Opinion in Urology|May 9, 2006
New drugs in prostate cancerAndrew J Armstrong, Michael A CarducciCurrent Opinion in Pharmacology|August 7, 2003
Differentiation therapyAlexander I Spira, Michael A CarducciCurrent Oncology Reports|April 26, 2005
Chemotherapy for advanced prostate cancer: results of new clinical trials and future studiesAndrew J Armstrong, Michael A CarducciCancer Journal (Sudbury, Mass.)|January 23, 2013
From bevacizumab to tasquinimod: angiogenesis as a therapeutic target in prostate cancerMichael T Schweizer, Michael A CarducciCancer Treatment Reviews|October 11, 2016
Early use of chemotherapy in metastatic prostate cancerMark C Markowski, Michael A CarducciWorld Journal of Urology|April 2, 2013
Are bisphosphonates an indispensable tool in the era of targeted therapy for renal cell carcinoma and bone metastases?Daniel Keizman, Maya Ish-Shalom, Natalie Maimon, et al.Harefuah|October 21, 2015
[THE CURRENT APPROACH TO ADVANCED LUNG CANCER]Maya Gottfried, Daniel Keizman, Moshe Mishaeli, et al.Cancer Research and Treatment|March 13, 2015
Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?Daniel Keizman, Keren Rouvinov, Avishay Sella, et al.European Journal of Cancer (Oxford, England : 1990)|March 14, 2012
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinomaDaniel Keizman, Maya Ish-Shalom, Roberto Pili, et al.Harefuah|October 21, 2015
[THE CURRENT APPROACH TO METASTATIC RENAL CELL CARCINOMA]Daniel Keizman, Natalie Maimon, Moshe Mishaeli, et al.Pageof 33